QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

HOME  |   SEARCH  |   ARCHIVE  |   SUBSCRIBE  |   CONTACT  |   HELP

This Article Full Text Full Text (PDF) Submit an eLetter Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (135) Citing Articles via Google Scholar Google Scholar Articles by Vaidya, V. A. Articles by Duman, R. S. Search for Related Content PubMed PubMed Citation Articles by Vaidya, V. A. Articles by Duman, R. S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH

 Previous Article  |  Next Article 

Volume 17, Number 8, Issue of April 15, 1997 pp. 2785-2795
Copyright ©1997 Society for Neuroscience

5-HT_2A Receptor-Mediated Regulation of Brain-Derived Neurotrophic Factor mRNA in the Hippocampus and the Neocortex

Received Oct. 17, 1996; revised Jan. 22, 1997; accepted Jan. 24, 1997.

Vidita A. Vaidya, Gerard J. Marek, George K. Aghajanian, and Ronald S. Duman

Laboratory of Molecular Psychiatry, Departments of Psychiatry and Pharmacology, Yale University School of Medicine, Connecticut Mental Health Center, New Haven, Connecticut 06508

The influence of 5-HT receptor agonists on the expression of BDNF in brain was determined. Administration of a hallucinogenic 5-HT_{2A /2C} receptor agonist, but not a 5-HT_1A receptor agonist, resulted in a significant but differential regulation of BDNF mRNA levels in hippocampus and neocortex. In the hippocampus, the 5-HT_{2A /2C} receptor agonist significantly decreased BDNF mRNA expression in the dentate gyrus granule cell layer but did not influence expression of the neurotrophin in the CA subfields. In parietal cortex and other neocortical areas, but not piriform cortex, the 5-HT_{2A /2C} receptor agonist dramatically increased the expression of BDNF mRNA. The effect of the 5-HT_{2A /2C} receptor agonist on BDNF mRNA in both the hippocampus and the neocortex was blocked by pretreatment with a selective 5-HT_2A, but not 5-HT_2C, receptor antagonist. The expression of BDNF mRNA in the hippocampus is reported to be decreased by stress, raising the possibility that the 5-HT_2A receptor mediates this effect. Pretreatment with ketanserin, a 5-HT_{2A /2C} receptor antagonist, significantly blocked the stress-induced downregulation of BDNF mRNA in hippocampus, in support of this hypothesis. The results of this study raise the possibility that regulation of BDNF expression by hallucinogenic 5-HT_2A receptor agonists leads to adaptations of synaptic strength in the hippocampus and the neocortex that may mediate some of the acute and long-term behavioral effects of these agents.

Key words: BDNF; 5-HT_2A; 5-HT_2C; hippocampus; cortex; DOI; stress

This article has been cited by other articles:

				L. Stankovski, C. Alvarez, T. Ouimet, T. Vitalis, K. H. El-Hachimi, D. Price, E. Deneris, P. Gaspar, and O. Cases Developmental Cell Death Is Enhanced in the Cerebral Cortex of Mice Lacking the Brain Vesicular Monoamine Transporter J. Neurosci., February 7, 2007; 27(6): 1315 - 1324. [Abstract] [Full Text] [PDF]

				T. Hajszan and N. J. MacLusky Neurologic links between epilepsy and depression in women: Is hippocampal neuroplasticity the key? Neurology, March 28, 2006; 66(66_suppl_3): S13 - S22. [Abstract] [Full Text]

				K. Goldapple, Z. Segal, C. Garson, M. Lau, P. Bieling, S. Kennedy, and H. Mayberg Modulation of Cortical-Limbic Pathways in Major Depression: Treatment-Specific Effects of Cognitive Behavior Therapy Arch Gen Psychiatry, January 1, 2004; 61(1): 34 - 41. [Abstract] [Full Text] [PDF]

				J. Gonzalez-Maeso, T. Yuen, B. J. Ebersole, E. Wurmbach, A. Lira, M. Zhou, N. Weisstaub, R. Hen, J. A. Gingrich, and S. C. Sealfon Transcriptome Fingerprints Distinguish Hallucinogenic and Nonhallucinogenic 5-Hydroxytryptamine 2A Receptor Agonist Effects in Mouse Somatosensory Cortex J. Neurosci., October 1, 2003; 23(26): 8836 - 8843. [Abstract] [Full Text] [PDF]

				W. J. Tyler, M. Alonso, C. R. Bramham, and L. D. Pozzo-Miller From Acquisition to Consolidation: On the Role of Brain-Derived Neurotrophic Factor Signaling in Hippocampal-Dependent Learning Learn. Mem., September 1, 2002; 9(5): 224 - 237. [Abstract] [Full Text] [PDF]

				G. S. Mitchell, T. L. Baker, S. A. Nanda, D. D. Fuller, A. G. Zabka, B. A. Hodgeman, R. W. Bavis, K. J. Mack, and E. B. Olson Jr. Physiological and Genomic Consequences of Intermittent Hypoxia: Invited Review: Intermittent hypoxia and respiratory plasticity J Appl Physiol, June 1, 2001; 90(6): 2466 - 2475. [Abstract] [Full Text] [PDF]

				H. E. Scharfman, J. H. Goodman, and A. L. Sollas Actions of Brain-Derived Neurotrophic Factor in Slices from Rats with Spontaneous Seizures and Mossy Fiber Sprouting in the Dentate Gyrus J. Neurosci., July 1, 1999; 19(13): 5619 - 5631. [Abstract] [Full Text] [PDF]

				Y. G. Ni, S. J. Gold, P. A. Iredale, R. Z. Terwilliger, R. S. Duman, and E. J. Nestler Region-Specific Regulation of RGS4 (Regulator of G-Protein-Signaling Protein Type 4) in Brain by Stress and Glucocorticoids: In Vivo and In Vitro Studies J. Neurosci., May 15, 1999; 19(10): 3674 - 3680. [Abstract] [Full Text] [PDF]

				R. A. Johnson, A. J. Okragly, M. Haak-Frendscho, and G. S. Mitchell Cervical Dorsal Rhizotomy Increases Brain-Derived Neurotrophic Factor and Neurotrophin-3 Expression in the Ventral Spinal Cord J. Neurosci., May 15, 2000; 20(10): RC77 - RC77. [Abstract] [Full Text] [PDF]

Home  |   Search  |   Archive  |   Subscribe  |   Contact  |   Help